All News
AGA Guideline: Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals
The American Gastroenterology Association has published its revised clinical practice guidelines for the prevention and treatment of hepatitis B virus (HBV) reactivation in at-risk patients, particularly those with immune-mediated disease, receiving immunomodulatory therapy and steroids.
Read ArticleOrthotics in Rheumatoid Arthritis
Orthotics are cost-effective, externally applied devices designed to stabilize the joints and provide a conservative measure to alleviate joint pain and improve function. Options include therapeutic shoes, shoe inserts, hand splints/braces, wrist support and finger splints. This article reviews some of the indications on the use of orthotics in patients with RA.
Read ArticleACR Applauds Second Round of Medicare Drug Price Negotiations
The American College of Rheumatology applauded the announcement of additional drugs subject to pricing negotiations with the Centers for Medicare & Medicaid Services. This second round includes nintedanib (Ofev) and apremilast (Otezla), which are used to treat common and rare rheumatologic conditions.
Read ArticleWeak Data (1.24.2025)
Dr. Jack Cush reviews the news and journal reports from RheumNow.com, and features Dr. Charity Dean, the Keynote speaker at RheumNow Live 2025, and why she is an inspiration.
Read ArticleHonoring Dr. Dafna Gladman
In December 2024, the Governor General appointed Dr. Dafna Gladman an officer to the Order of Canada, which includes some of Canada's most notable Clinicians and Scientists. Created in 1967, the Order of Canada is one of Canada's highest civilian honours. It recognizes individuals whose achievements and service have had an impact on communities across Canada and beyond.
Read ArticleACR: Congress Fails to Reform PBMs, Mitigate Medicare Cuts
The American College of Rheumatology (ACR) commended the limited extension of key Medicare telehealth coverage provisions but also expressed disappointment that Members of Congress have failed to pass measures to bring transparency to pharmacy benefit manager (PBM) practices, address flawed insur
Read Article
Links:
Links:


